Literature DB >> 11106890

Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure.

O H Klungel1, A de Boer, A H Paes, N J Nagelkerke, J C Seidell, A Bakker.   

Abstract

The objective of our study was to assess the applicability of using estimates of within-person variance (WPV) from reproducibility studies for a correction of blood pressure values in another study to improve the accuracy of the prevalence estimation of hypertension. Data were collected from two cross-sectional population-based studies on cardiovascular disease risk factors conducted from 1987 to 1995 among 55,026 subjects aged 20-59 years. Correction factors were calculated from a reproducibility study among 924 subjects who were examined in 1989 and 1990. All other studies with repeated measurements of blood pressure were searched in MEDLINE from 1966 onward. Six studies satisfied the inclusion criteria. The prevalence of hypertension, uncorrected and corrected with factors from other studies, were compared with the prevalence of hypertension corrected with the factor from our study. The uncorrected prevalence of hypertension was 17.3% [95%CI:17.0-17.7]. The prevalence of hypertension after correction for WPV with the factor from our study was 13.5% [95%CI:13.2-13.8]. Correction for WPV with factors from the appropriate studies (depending on factors such as number of measurements taken per visit, and time interval between visits) resulted in prevalences ranging from 13.9% to 14.7%. The bias that occurs when no correction for WPV is performed is much larger (29% overestimation) than the bias that occurs when correction factors are derived from other studies (3.1-8.4% overestimation). When repeated measurements of blood pressure are not available in a population study for a sample of that same study, it is advisable to use data from another study to correct for WPV.

Entities:  

Mesh:

Year:  2000        PMID: 11106890     DOI: 10.1016/s0895-4356(00)00228-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

Review 1.  Does blood pressure variability modulate cardiovascular risk?

Authors:  Peter M Rothwell
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

2.  Undertreatment of hypercholesterolaemia: a population-based study.

Authors:  A K Mantel-Teeuwisse; W M M Verschuren; O H Klungel; D Kromhout; A D Lindemans; J Avorn; A J Porsius; A de Boer
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

3.  Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus.

Authors:  George Stojan; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2019-06-15       Impact factor: 4.666

4.  Age-related blood pressure patterns and blood pressure variability among hemodialysis patients.

Authors:  Mark R Rohrscheib; Orrin B Myers; Karen S Servilla; Christopher D Adams; Dana Miskulin; Edward J Bedrick; William C Hunt; Douglas E Lindsey; Darlene Gabaldon; Philip G Zager
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

5.  Prevalence of self-reported hypertension and its relation to dietary habits, in adults; a nutrition & health survey in Greece.

Authors:  Christos Pitsavos; George A Milias; Demosthenes B Panagiotakos; Dimitra Xenaki; George Panagopoulos; Christodoulos Stefanadis
Journal:  BMC Public Health       Date:  2006-08-13       Impact factor: 3.295

6.  Medication class effects on visit-to-visit variability of blood pressure measurements: analysis of electronic health record data in the "real world".

Authors:  Timothy R Smith; Joseph P Drozda; Jeffrey A Vanslette; Amanda S Hoeffken; Robert A Nicholson
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-12       Impact factor: 3.738

7.  Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

Authors:  Rosalinde K E Poortvliet; Ian Ford; Suzanne M Lloyd; Naveed Sattar; Simon P Mooijaart; Anton J M de Craen; Rudi G J Westendorp; J Wouter Jukema; Christopher J Packard; Jacobijn Gussekloo; Wouter de Ruijter; David J Stott
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.